title: Metallothionein provides ubiquinone-mediated neuroprotection in Parkinson's disease.
authors.affiliation: Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, P.O. Box 9037, 501 North Columbia Road, Grand Forks, ND 58203, USA. mebadi@medicine.nodak.edu
authors.forename: Manuchair
authors.initials: M
authors.lastname: Ebadi
authors.forename: Sushil
authors.initials: S
authors.lastname: Sharma
authors.forename: Dhanasekaran
authors.initials: D
authors.lastname: Muralikrishnan
authors.forename: Shaik
authors.initials: S
authors.lastname: Shavali
authors.forename: Josh
authors.initials: J
authors.lastname: Eken
authors.forename: Patcharee
authors.initials: P
authors.lastname: Sangchot
authors.forename: Banthit
authors.initials: B
authors.lastname: Chetsawang
authors.forename: Leah
authors.initials: L
authors.lastname: Brekke
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects; D006801:Humans; D008668:Metallothionein / Q000494:pharmacology*; D008928:Mitochondria / Q000187:drug effects; D019636:Neurodegenerative Diseases / Q000473:pathology / Q000517:prevention & control; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology*; D014451:Ubiquinone / Q000378:metabolism / Q000502:physiology*
chemical_list: D018696:Neuroprotective Agents; D014451:Ubiquinone; D008668:Metallothionein